Condition: Metastatic Soft Tissue Sarcoma · Unresectable Soft Tissue Sarcoma · Sponsor: Adcendo ApS
The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01.
This description comes directly from the study's public registry record.
René Smrčka · +45 3144 0653 · rene.smrcka@adcendo.com
Margaret McNaull · +44 7818 457619. · margaret.mcnaull@adcendo.com
Always discuss trial participation with your own doctor first.
| University of Colorado Denver | Aurora, Colorado, United States | Recruiting |
| University of Miami - Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| University Of Texas MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Universitair Ziekenhuis Leuven (UZ Leuven) - Campus Gasthuisberg | Leuven, Belgium | Recruiting |
| Centre Léon Bérard | Lyon, France | Recruiting |
| Universitätsklinikum Essen West German Tumor Center | Essen, Germany | Recruiting |
| Royal Marsden | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06797999